Differential Expression and Potential Value of c-MYC in Non-Invasive and Invasive Mammary Carcinoma
NCT06357338 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2024-04-10
Summary
Retrospective observational study to evaluate c-MYC expression in non invasive and invasive mammry carcinoma
Conditions
Interventions
- OTHER
-
no intervention
No intervention
Sponsors & Collaborators
-
Qena Oncology Center
collaborator OTHER_GOV -
Marwa Mahmoud Hassan
lead OTHER
Principal Investigators
-
Afaf Alnashar, professor · Sohag University
Eligibility
- Min Age
- 15 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-19
- Primary Completion
- 2025-04-01
- Completion
- 2026-04-01
Countries
- Egypt
Study Locations
More Related Trials
-
Study on the Correlation Between the Quantitative Parameters of Mr Mean Cell Size Imaging and the Histopathological Characteristics of Breast Cancer
NCT05373628 ·Status: UNKNOWN ·Phase: NA
-
Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer Patients
NCT05733026 ·Status: UNKNOWN
-
Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in Brazil
NCT05034393 ·Status: COMPLETED
-
Transcriptional and Epimetabolic Profile of Breast Carcinoma With Luminal or HER2+ or Locally Advanced Triple-negative Histotype in Patients With/Without Previous Clinical History of Metabolic Syndrome
NCT06261918 ·Status: RECRUITING
-
Prognostic Value of Biomarkers in HR + / HER2 - Advanced Breast Cancer
NCT04683770 ·Status: UNKNOWN
-
The Effect of Metformin on Breast Cancer Patients
NCT04559308 ·Status: UNKNOWN ·Phase: PHASE2
-
Diagnostic Biomarkers Exploration of Breast Cancer From Serum and Urine
NCT06102018 ·Status: RECRUITING
-
A Multicenter, Open and Observational Real World Study on the Prognosis and Treatment in Young Women With Breast Cancer
NCT04970264 ·Status: UNKNOWN
-
The Effect of Body Mass Index and Total Cholesterol Levels on Histopathological Grading in Breast Cancer Patients
NCT06786598 ·Status: COMPLETED ·Phase: NA
-
The Diagnosis and Prognosis of Nonpalpable Breast Cancer Detected by the US vs Mammography: a Clinical Noninferiority Trial.
NCT04360616 ·Status: UNKNOWN
-
Miti-gene Recurrence Score in HR+/HER2- Chinese Breast Cancer Patients
NCT07052734 ·Status: COMPLETED
-
Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer
NCT04920656 ·Status: COMPLETED
-
Cardiac Toxicity of Hypo Fractionated Radiotherapy in Left Breast Cancer
NCT05358093 ·Status: UNKNOWN
-
A Study Comparing the Differences Between Young and Non-young Breast Cancer
NCT06793306 ·Status: ENROLLING_BY_INVITATION
-
Triple-negative Breast Cancer: a New Perspective on Biomarkers
NCT03539965 ·Status: COMPLETED
-
Internet Use Among Women With Recurrent Metastatic Breast Cancer
NCT00770055 ·Status: COMPLETED ·Phase: NA
-
Patterns of Breast Cancer Management and Prognosis of Breast Cancer in China
NCT04076111 ·Status: NOT_YET_RECRUITING
-
Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging
NCT05809128 ·Status: UNKNOWN
-
Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients
NCT05326295 ·Status: RECRUITING
-
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis
NCT06427720 ·Status: COMPLETED
-
Assessment of Candidate Protein Expression in Breast Cancer Specimens
NCT00918892 ·Status: COMPLETED
-
The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study
NCT05463276 ·Status: COMPLETED
-
An AI Model Predicts the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer: a Multicenter, Bidirectional Cohort Study
NCT06510127 ·Status: ENROLLING_BY_INVITATION
-
Discordant HER2/Neu Status of Breast Cancer.
NCT01935739 ·Status: COMPLETED
-
Diagnostic and Prognostic Value of MicroRNA in Breast Cancer Patients
NCT04778202 ·Status: UNKNOWN